Home/Allterum Therapeutics/Jack Schaumberg, PhD

JS

Jack Schaumberg, PhD

Director of Clinical Operations

Allterum Therapeutics

Therapeutic Areas

Oncology Hematologic Malignancies

Allterum Therapeutics Pipeline

Drug	Indication	Phase
4A10	Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (ALL)	Pre-clinical

Leadership Team at Allterum Therapeutics

Yan Moore, MD, MBA

Chief Executive Officer

Atul Varadhachary, MD, PhD

President/Executive Chairman

Mark Worscheh, MBA

Chief Financial Officer

View full Allterum Therapeutics profile